Cambridge’s T2 Biosystems, a developer of portable medical diagnostic products combining nanotechnology and miniaturized magnetic resonance imaging technology, today announced that John McDonough has been named its new CEO. McDonough, previously president of medical diagnostics and devices company Cytyc Development, will also join T2’s board of directors.

Bob is Xconomy's founder and editor in chief. You can e-mail him at bbuderi@xconomy.com, call him at 617.500.5926. Follow @bbuderi

• Share on Facebook
• Share on Twitter
• LinkedIn
• Email
• Reprints

Trending on Xconomy

• Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More
• The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski
• Vikram Jandhyala, Champion of Innovation at UW and Beyond, Dies at 47